The gamma delta T therapy industry is currently experiencing a surge in activity, with Adicet Bio, Leucid, Century, Imcheck, IN8bio, Sanofi, and Takeda among the leading companies competing to develop effective treatments for solid tumors. With mounting evidence of clinical efficacy, these companies are investing heavily in research and development
25-27 July 2023